Research links anti-seizure drug to birth defects

07/22/2008 | Bloomberg

The rate of children born with cleft palates or cleft lips was 11 times higher among female patients taking Topamax, Johnson & Johnson's anti-seizure drug, alone or with other medication, according to a study of 203 pregnancies. For boys, a genital defect was 14 times higher than normal. The U.K. researchers said the findings are similar to those from studies of other epilepsy treatments, but a bigger study is necessary to get more conclusive results.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ